Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Fosun International ( (HK:0656) ) has provided an update.
Fosun International has announced an extraordinary general meeting to approve the adoption of the 2025 H Share RSU Scheme for Fosun Pharma. This move is expected to enhance Fosun Pharma’s employee incentive program, potentially improving operational efficiency and aligning stakeholder interests with company performance.
The most recent analyst rating on (HK:0656) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Fosun International stock, see the HK:0656 Stock Forecast page.
More about Fosun International
Fosun International is a diversified investment and holding company with a focus on various industries including healthcare, tourism, and finance. It is known for its strategic investments and operations in multiple sectors, aiming to create a global ecosystem of products and services.
Average Trading Volume: 14,915,912
Technical Sentiment Signal: Buy
Current Market Cap: HK$43.67B
See more insights into 0656 stock on TipRanks’ Stock Analysis page.